MATHEW CANNAVA, M.D.
Dermatology Physician in SOLDOTNA, Alaska. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MATHEW CANNAVA, M.D. reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 456 Medicare Part D claims in 2023.
- 0/100
- MIPS score · -83 vs avg
- 456
- Part D claims, 2023
- 93%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MATHEW CANNAVA, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
0 0th percentile higher than 0% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
MATHEW CANNAVA, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about MATHEW CANNAVA, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Alaska
How Dermatology Physician compares to other specialties among Alaska providers
Dermatology Physician share within Alaska
Dermatology Physician is one of the more visible NUCC categories in Alaska
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MATHEW CANNAVA, M.D.'s 2023 MIPS final score plotted against the Dermatology Physician national average
- MIPS Final Score
- 0/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Dermatology Physician) — 0/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Dermatology Physician US NPIs
0/100 MIPS final score — 83.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Dermatology Physician. Quality dim: 0.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MATHEW CANNAVA, M.D. is a Dermatology Physician provider practicing in SOLDOTNA, Alaska, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1245368695. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
MATHEW CANNAVA, M.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D. credentials at 247 N FIREWEED ST, SOLDOTNA, AK, 99669, with a listed phone of (907) 262-7546. NPI 1245368695 was issued on 02/28/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CANNAVA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 456 prescription claims written by this provider, covering 247 Medicare beneficiaries and totaling roughly $140K in drug spend, split 7% brand-name and 93% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.
Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1245368695 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 02/28/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MATHEW CANNAVA, M.D.'s current license status, disciplinary history, and board certifications with the Alaska State Medical Board in Alaska before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Brand vs generic prescribing mix · Generic-heavy
7% brand-name claims vs 93% generic, on 456 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 559
- Total Day Supply
- 14,065
- Brand vs Generic
- 7% brand / 93% generic
- Brand Drug Cost
- $121K
- Generic Drug Cost
- $19K
- Antibiotic Claims
- 72
Patient Demographics
- Average Patient Age
- 74.9 years
- Avg HCC Risk Score
- 0.92
- Gender Split
- 37% female / 63% male
- Age Distribution
- <65: 13, 65-74: 111, 75-84: 95, 85+: 28
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Triamcinolone Acetonide | 94 |
| Imiquimod | 50 |
| Cephalexin | 45 |
| Clobetasol Propionate | 34 |
| Fluorouracil | 34 |
| Ketoconazole | 23 |
| Minocycline Hcl | 22 |
| Hydrocortisone | 20 |
| Humira Adalimumab | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How MATHEW CANNAVA, M.D. fits within the Dermatology Physician landscape nationally.
MATHEW CANNAVA, M.D.'s 456 claims are below the specialty average of 729.
Nearby Dermatology Physician Providers in Alaska
Other clinicians with the same primary specialty enrolled in Alaska, drawn from the same CMS NPPES roster as CANNAVA.
Compare Dermatology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Alaska
Frequently Asked Questions
What is MATHEW CANNAVA, M.D.'s specialty? ▼
How much does MATHEW CANNAVA, M.D. prescribe under Medicare Part D? ▼
What is MATHEW CANNAVA, M.D.'s Medicare quality score? ▼
Where is MATHEW CANNAVA, M.D. located? ▼
What is MATHEW CANNAVA, M.D.'s NPI number? ▼
Does MATHEW CANNAVA, M.D. prescribe more brand-name or generic drugs? ▼
How many Dermatology Physician providers are there in the US? ▼
What drugs does MATHEW CANNAVA, M.D. prescribe most often? ▼
Does MATHEW CANNAVA, M.D. accept Medicare? ▼
How can I verify MATHEW CANNAVA, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology